| Name | Title | Contact Details |
|---|
From strategy to execution. We help our clients to be visionary in their ambition, and pragmatic in their realization Many strategies fail due to a lack of effective execution. At Strategy&, we work with our clients to solve their toughest problems by coming up with a strategy that is executable – defined by clear choices and a strong vision for the future. We have the required expertise and work hand-in-hand with our colleagues from the PwC network. The result: reliable strategy consulting – from initial analysis to measurable results and sustainable outcomes. Driven by a spirit of innovation and guided by pragmatism, a professional attitude, empathy, and a strong sense of responsibility. This is how we make strategy real at Strategy&.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Aiwyn helps leading accounting firms automate and optimize critical revenue processes by unlocking client data from existing practice management and CRM systems with our Practice Automation platform. With Aiwyns Practice Automation platform, high-value firm executives, partners, and staff are liberated to deliver more value to clients and work at the highest end of their professional expertise. Benefits of Practice Automation to accounting firms include: - save time, bill faster - eliminate tedious back office tasks - reduce days-in-WIP and days-in-AR, - speed up client payments - smooth out cash flow - protect financial health with predictive insights and controls - offer a best-in-class experience to both employees and clients
iwis is one of the worlds leading suppliers of chain system solutions for the automotive industry as well as for drive and conveyor purposes in numerous industries. What began with a bicycle chain quickly grew into a successful, likeable family business - and ultimately into a global technology leader in the field of high-quality chain system solutions and engineering service provider. By expanding our product range with high-precision stamped and bent parts as well as precision plastic parts, multi-component and composite parts, we continue to lead the automotive sector towards the future in terms of mobility and regenerative energy generation. Our product brands JWIS, ELITE,FLEXON as well as EUROCHAIN, ECOPLUS and MEGALIFE offer suitable solutions for every quality requirement. Our team counts more than 3,000 employees working at numerous international locations: dedicated professionals working in the 3 divisions Mobility Systems, Drive Systems, and Mechatronics on development and optimization as well as in manufacturing and quality testing. For solutions that really move the world. Our goal is perfection - no more, no less. The expertise of our engineers lies in identifying trends, developing new material and manufacturing technologies, and customized solutions. Our research and development competence center stands for innovation and partnership. This makes us a strong and reliable partner. Imprint: https://www.iwis.com/en-gb/imprint